816454-25-8

• 常用中文名：1,2-二苄基 3-叔丁基哌嗪-1,2,3-三羧酸
• 常用英文名：1,2-Dibenzyl 3-tert-butyl piperazine-1,2,3-tricarboxylate
• CAS号：816454-25-8
• 分子式：C₂₅H₃₀N₂O₆
• 分子量：454.51600
• 发布时间：2018-11-26 19:04:16
• 更新时间：2024-01-12 13:04:28

名称

• 中文名: 1,2-二苄基 3-叔丁基哌嗪-1,2,3-三羧酸
• 英文名: 1-O,2-O-dibenzyl 3-O-tert-butyl piperazine-1,2,3-tricarboxylate
• 英文别名: 1,2-dibenzyl-3-tert-butyl piperazine-1,2,3-tricarboxylate; (S)-1,2-dibenzyloxycarbonylpiperazic acid; (S)-1,2-di(benzyloxycarbonyl)hexahydropyridazine-3-carboxylic acid; (3S)-Tetrahydro-1,2,3-pyridazinetricarboxylic acid 1,2-bis(phenylmethyl) ester

物化性质

• 分子式: C₂₅H₃₀N₂O₆
• 分子量: 454.51600
• 精确质量: 454.21000
• PSA: 94.17000
• LogP: 3.31740

安全

• 海关编码: 2933599090

合成路线

816454-17-8 ~91% 816454-25-8

文献：Henmi, Yoshiaki; Makino, Kazuishi; Yoshitomi, Yayoi; Hara, Osamu; Hamada, Yasumasa Tetrahedron Asymmetry, 2004 , vol. 15, # 21 p. 3477 - 3481

1191-30-6 ~% 816454-25-8

文献：Henmi, Yoshiaki; Makino, Kazuishi; Yoshitomi, Yayoi; Hara, Osamu; Hamada, Yasumasa Tetrahedron Asymmetry, 2004 , vol. 15, # 21 p. 3477 - 3481

816454-12-3 ~% 816454-25-8

文献：Henmi, Yoshiaki; Makino, Kazuishi; Yoshitomi, Yayoi; Hara, Osamu; Hamada, Yasumasa Tetrahedron Asymmetry, 2004 , vol. 15, # 21 p. 3477 - 3481

2449-05-0 ~% 816454-25-8

文献：Henmi, Yoshiaki; Makino, Kazuishi; Yoshitomi, Yayoi; Hara, Osamu; Hamada, Yasumasa Tetrahedron Asymmetry, 2004 , vol. 15, # 21 p. 3477 - 3481

816454-01-0 ~% 816454-25-8

文献：Henmi, Yoshiaki; Makino, Kazuishi; Yoshitomi, Yayoi; Hara, Osamu; Hamada, Yasumasa Tetrahedron Asymmetry, 2004 , vol. 15, # 21 p. 3477 - 3481

816454-06-5 ~% 816454-25-8

文献：Henmi, Yoshiaki; Makino, Kazuishi; Yoshitomi, Yayoi; Hara, Osamu; Hamada, Yasumasa Tetrahedron Asymmetry, 2004 , vol. 15, # 21 p. 3477 - 3481

上下游产品

上游产品  5
816454-17-8 1191-30-6 2449-05-0 816454-01-0
816454-06-5
下游产品  0

海关

海关编码	2933599090
中文概述	2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期
Summary	2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%